Home > Insider Trading > Filing (0001104659-21-076401)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1621227	Adaptimmune Therapeutics Plc	ADAP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1553053	M Lawrence Alleva	C/O Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park Abingdon X0 OX14 4RX		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share	Acquisiton	2021-06-01	12,600	$0.79	12,600	No	4	P	Indirect	Held by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share	60,180	Indirect	Held by Trust
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share	70,584	Direct

Footnotes

The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
The 12,600 ordinary shares reported in Column 4 and Column 5 are represented by 2,100 ADSs.
The price reported in Column 4 of $0.79 per ordinary share is derived from the weighted average purchase price paid on June 1, 2021 of $4.745 per ADS divided by six.
The 60,180 ordinary shares reported in Column 5 are represented by 10,030 ADSs. These shares are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust.
The 70,584 ordinary shares reported in Column 5 are represented by 11,764 ADSs. These shares are held in the form of ADSs by Mr. Alleva.